Efficiency Perspectives on Adaptive Designs in Stroke Clinical Trials-Reference-Cited by-同舟云学术

Efficiency Perspectives on Adaptive Designs in Stroke Clinical Trials

Published:2011-10 Issue:10 Volume:42 Page:2990-2994
ISSN:0039-2499
Container-title:Stroke
language:en
Short-container-title:Stroke

Author:

Cheung Ken¹,Kaufmann Petra¹

Affiliation:

1. From the Department of Biostatistics, Columbia University (K.C.), New York, NY; National Institute of Neurological Disorders and Stroke (P.K.), North Bethesda, MD.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialized Nursing,Cardiology and Cardiovascular Medicine,Neurology (clinical)

Reference27 articles.

1. Tissue Plasminogen Activator for Acute Ischemic Stroke

2. U.S. Food and Drug Administration. Draft guidance for industry on adaptive design clinical trials for drugs and biologics. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm201790.pdf. February 2010. Accessed May 31 2011.

3. ON THE LIKELIHOOD THAT ONE UNKNOWN PROBABILITY EXCEEDS ANOTHER IN VIEW OF THE EVIDENCE OF TWO SAMPLES

4. A Two-Sample Test for a Linear Hypothesis Whose Power is Independent of the Variance

5. A Stochastic Approximation Method

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modified Rankin Scale disability status at day 4 poststroke is an informative predictor of long-term day 90 outcome;Journal of Stroke and Cerebrovascular Diseases;2024-11

2. Modified Rankin Scale Disability Status at Day 4 Poststroke is an Informative Predictor of Long-Term Day 90 Outcome;2023-07-01

3. The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de‐risk trial programmes of novel agents;World Psychiatry;2023-01-14

4. How can imaging in acute ischemic stroke help us to understand tissue fate in the era of endovascular treatment and cerebroprotection?;Neuroradiology;2022-07-20

5. Early-Phase Platform Trials: A New Paradigm for Dose Finding and Treatment Screening in the Era of Precision Oncology;JCO Precision Oncology;2019-12